中文名称:乙酰恩格列净

中文别名:(1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇;乙酰恩格列净;(1S)-1,5-脱水-1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-D-山梨糖醇四乙酸酯;5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇;过乙酰基依帕列净;依帕列净杂质25;恩格列净杂质007;(2R,3R,4R,5S,6S)-2-(乙酰氧甲基)-6-(4-氯-3-(4-(环丁氧基)苄基)苯基)四氢-2H-吡喃-3,4,5-三醋酸酯

英文名称:Acetoxy Empagliflozin

英文别名:(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydro-3-furanyloxy]benzyl}phenyl)-D-glucitol;Empagliflozin Impurity 25;(1S)-1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl] methyl]phenyl]-D-Glucitol;Acetoxy Empagliflozin;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol tetraacetate;Empagliflozin impurity 13/Peracetyl Empagliflozin/(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)- tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran- 3,4,5-triyl triacetate;[(2R,3R,4R,5S,6S)-3,4,5-Triacetyloxy-6-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]oxan-2-yl]methyl acetate;Peracetyl Empagliflozin

CAS:915095-99-7

EINECS:1592732-453-0

分子式:C31H35ClO11

分子量:619.06

分子结构:

危险标志:-

风险术语:-

安全术语:-

物化性质:-

熔点:-

相对密度:1.33±0.1 g/cm3(Predicted)

溶解性:-

用途:乙酰恩格列净是合成恩格列净的中间体。恩格列净(empagliflozin)由勃林格殷格翰和礼来合作开发，是一种钠-葡萄糖协同转运蛋白(SGLT2)抑制剂，可用于治疗2型糖尿病。目前已在美国、欧洲、日本等多个国家上市销售。

上游原料:-

下游产品:-